NDC11 80830169103

This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.

Possible FDA NDC forms#

Package NDC, Product root table
Package NDC	Product root
80830-1691-03	80830-1691
80830-1691-3	80830-1691

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
POTASSIUM PHOSPHATES	POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,	Amneal Pharmaceuticals Private Limited	98315c6e-308d-423b-a046-4be1f54d30ae	2026-09-01	Warnings, Adverse reactions	Exact identifier ndc (product): 80830-1691
POTASSIUM PHOSPHATES	POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,	Amneal Pharmaceuticals Private Limited	125121b8-bc4c-44ee-906e-e72f652a5aa6	2026-09-01	Warnings, Adverse reactions	Exact identifier ndc (package): 80830-1691-3 ndc (product): 80830-1691 ndc11 (package): 80830169103
POTASSIUM PHOSPHATES	POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,	Amneal Pharmaceuticals Private Limited	89136c51-a60b-4269-bd05-9489f060a734	2024-12-31	Warnings, Adverse reactions	Exact identifier ndc (product): 80830-1691

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.